Progesterone Study For Traumatic Brain Injury Now in Third Phase

Preliminary research studies at Emory University, Atlanta, Georgia have shown that patients who receive progesterone injections shortly after sustaining a severe head or severe brain injury have reduced risk of death and long term disability.  The small pilot study had enrolled 100 Participants.

Now the National Institute of Health (NIH) has provided an additional 14.5 million dollars for a three year comprehensive study that will enroll 1,140 patients at 17 medical centers across 17 states to further study the protective effects of progesterone in minimizing death and the long term consequences of traumatic brain injury. 

Read the full Emory press release: progesterone for traumatic brain injury.